CLINICAL_TRIALS
trial_result
· 2019-04-26
Clinical Trial Update: Abobotulinumtoxina Efficacy in Post-Traumatic Headache [Phase 4]
Summary
Phase 4 trial update evaluating abobotulinumtoxinA (Botulinum toxin type A) for efficacy in post-traumatic headache; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VA Greater Los Angeles Healthcare System | Conditions: Post-Traumatic Headache | Phase 4 | Status: COMPLETED